Extracellular Vesicles as Potential Biomarkers in Addictive Disorders.

Autor: Severtsev VV; Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119048, Russia. severtsevmed@gmail.com.; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical-Biological Agency of the Russian Federation, Moscow, 143007, Russia., Pavkina MA; Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119048, Russia., Ivanets NN; Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119048, Russia., Vinnikova MA; Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119048, Russia.; Moscow Scientific and Practical Center of Narcology, Moscow Healthcare Department, Moscow, 109390, Russia., Yakovlev AA; Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, 117485, Russia.; Research and Clinical Center for Neuropsychiatry, Moscow Healthcare Department, Moscow, 115419, Russia.

Publikováno v: Biochemistry. Biokhimiia [Biochemistry (Mosc)] 2024 Nov; Vol. 89 (11), pp. 1970-1984.

Atypical antipsychotics in the treatment of patients with a dual diagnosis of schizophrenia spectrum disorders and substance use disorders: the results of a randomized comparative study.

Autor: Skryabin VY; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia., Vinnikova MA; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Scientific Department, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia., Ezhkova EV; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Titkov MS; Psychiatry and Psychotherapy Division, European Medical Centre, Moscow, Russia., Bulatova RA; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.

Publikováno v: Journal of addictive diseases [J Addict Dis] 2021 Oct-Dec; Vol. 39 (4), pp. 513-525. Date of Electronic Publication: 2021 Apr 09.

Management of schizophrenia and comorbid substance use disorders: expert review and guidance.

Autor: Neyra, Adrián¹ aneyros@gobiernodecanarias.org, Parro-Torres, Carlos², Ros-Cucurull, Elena³, Carrera, Indalecio⁴, Echarri, Eduardo⁵, Torrens, Marta⁶

Publikováno v: Annals of General Psychiatry. 10/30/2024, Vol. 23 Issue 1, p1-9. 9p.

[Clinical presentations and therapy of polysubstance dependence in patients with schizophrenia].

Autor: Ivanets NN; Sechenov First Moscow State Medical University, Moscow, Russia., Vinnikova MA; Moscow Research and Practical Center on Addictions, Moscow, Russia., Ezhkova EV; Moscow Research and Practical Center on Addictions, Moscow, Russia., Titkov MS; European Medicine Center, Moscow, Russia., Bulatova RA; Moscow Research and Practical Center on Addictions, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2021; Vol. 121 (4), pp. 63-69.

Non-medical Use of Naphazoline (Naphthyzin): Two Case Reports.

Autor: Skryabin VY; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia (VYS, MAV, SDK, AGK); IM Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia (MAV)., Vinnikova MA, Komarov SD, Khvan AG

Publikováno v: Journal of addiction medicine [J Addict Med] 2020 Sep/Oct; Vol. 14 (5), pp. e267-e270.